| Logo | Name | Σ | ||
|---|---|---|---|---|
 | Sofinnova Partners Sofinnova Partners is a leading European VC firm in life sciences, specializing in healthcare and sustainability. Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential … | 255 | 119 | 142 |
 | Métropole Européenne de Lille (MEL) [Automatic translation follows] Public Establishment for Intercommunal Cooperation (EPCI) serving 95 municipalities for more than a million inhabitants. The European Metropolis of Lille, a public establishment for intermunicipal cooperation, brings together more than a million inhabitants and 95 municipalities. Its territory is both rural and urban, made up of large towns and villages. It exercises its skills in 19 essential areas serving users such as planning, roads, sanitation, transport, culture, tourism, housing, economic development, etc. MEL services include more than 2,800 agents and more than 100 professions. Supported by an ambitious continuing training policy, they open up attractive professional development … Sectors: | 1160 | 907 | 208 |
 | Clubster NSL [Automatic translation follows] 350 members | #innovation #health #nutrition #longevity | contact@clubster-nsl.com Clubster Santé, a network of health companies in the Nord-Pas de Calais region, aims to develop, promote, represent and lead the regional health sector. Our network carries major unifying missions: being the spokesperson for the regional health sector, facilitating exchanges and partnerships between companies and supporting a dynamic and wealth-creating sector via a specialized investment platform. Personalized medicine, Inter-company training, HIPÂ, Concept Room, Invest'Innove, Investment platform, Information, Pooling, Innovation, Networking, Business Angels Academy, nutrition, longevity, and eurasanté Sectors: | 244 | 85 | 183 |
 | France Biotech Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: … Sectors: | 586 | 345 | 370 |
 | Eurasanté Accélérateur des innovations santé-nutrition, bien vieillir en région Hauts-de-France Eurasanté is a regional economic development agency specialized in the the health sector. It supports the different actors dedicated to health related activities with their research, creation and development projects. The Biology, Nutrition and Health Sector of the Nord-Pas-De-Calais represents 800 companies, and 22 000 employees. Located at the heart of a business park of over 300 hectares gathering 7 hospitals, 50 research laboratories, 145 companies, 4 universities, 5 specialized training institutes, it constitutes a unique business environment in the largest university-hospital campus over Europe. 3 kinds of services are part … Sectors: | 311 | 171 | 170 |
 | Ipsen We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries. For more information, visit ipsen.com. Pharmaceuticals, Specialty care: oncology, neuroscience, endocrinology, Research: peptides, toxins, and Primary Care Sectors: | 182 | 145 | 34 |
French metropolis